Docebo Inc 6-K, filed May 12, 2022
Docebo Inc. (DCBO)
6-K
2022-05-12
For: 2022-03-31
View Original
Added on
April 08, 2026
About this 6-K
Docebo Inc filed this 6-K on May 12, 2022.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2022
Commission File Number 001-39750
(Exact name of Registrant as specified in its charter)
N/A
(Translation of Registrant’s name)
(800) 681-4601
(Address and telephone number of registrant’s principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
| Form 20-F | ☐ | Form 40-F | ☒ | |||||||||||
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
INCORPORATION BY REFERENCE
Exhibits 99.1, 99.2, 99.4 and 99.5 of this Form 6-K are incorporated by reference to the registrant's Registration Statement on Form F-10 (File No. 333-251046), the registrant’s Registration Statement on Form S-8 (File No. 333-251417) and the registrant’s Registration Statement on Form F-3 (File No. 333-262000).
DOCUMENTS INCLUDED AS PART OF THIS REPORT
| Exhibit | ||||||||
| 99.1 | ||||||||
| 99.2 | ||||||||
| 99.3 | ||||||||
| 99.4 | ||||||||
| 99.5 | ||||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Docebo Inc. | ||||||||||||||||||||
| Date: | May 12, 2022 | By: | /s/ Sukaran Mehta | |||||||||||||||||
| Name: | Sukaran Mehta | |||||||||||||||||||
| Title: | Chief Financial Officer | |||||||||||||||||||
| Exhibit 99.1 | ||
| DOCEBO INC. | ||
UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION | ||
| (expressed in thousands of United States dollars) | ||
| March 31, | December 31, | ||||||||||
| 2022 | 2021 | ||||||||||
| $ | $ | ||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | |||||||||||
Trade and other receivables (Note 4) | |||||||||||
| Prepaids and deposits | |||||||||||
| Net investment in finance lease | |||||||||||
Contract costs, net | |||||||||||
| Non-current assets: | |||||||||||
Contract costs, net | |||||||||||
| Net investment in finance lease | |||||||||||
| Deferred tax asset | |||||||||||
Right-of-use assets, net (Note 5) | |||||||||||
Property and equipment, net (Note 6) | |||||||||||
Intangible assets, net (Note 7) | |||||||||||
Goodwill (Note 8) | |||||||||||
| Liabilities | |||||||||||
| Current liabilities: | |||||||||||
| Trade and other payables | |||||||||||
| Income taxes payable | |||||||||||
Deferred revenue | |||||||||||
| Contingent consideration | |||||||||||
Lease obligations (Note 5) | |||||||||||
| Non-current liabilities: | |||||||||||
| Contingent consideration | |||||||||||
Deferred revenue | |||||||||||
Lease obligations (Note 5) | |||||||||||
Employee benefit obligations | |||||||||||
Deferred tax liability | |||||||||||
| Shareholders’ equity | |||||||||||
Share capital (Note 10) | |||||||||||
| Contributed surplus | |||||||||||
Accumulated other comprehensive income | |||||||||||
Deficit | ( | ( | |||||||||
| Total equity | |||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.
1
| DOCEBO INC. | ||
UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF LOSS AND COMPREHENSIVE LOSS | ||
| (expressed in thousands of United States dollars, except per share amounts) | ||
Three months ended March 31, | |||||||||||||||||||||||
| 2022 | 2021 | ||||||||||||||||||||||
| $ | $ | ||||||||||||||||||||||
Revenue (Note 13) | |||||||||||||||||||||||
Cost of revenue (Note 14 and 15) | |||||||||||||||||||||||
| Gross profit | |||||||||||||||||||||||
| Operating expenses | |||||||||||||||||||||||
General and administrative (Note 15) | |||||||||||||||||||||||
Sales and marketing (Note 15) | |||||||||||||||||||||||
Research and development (Note 15) | |||||||||||||||||||||||
Share-based compensation (Note 11) | |||||||||||||||||||||||
Foreign exchange loss | |||||||||||||||||||||||
Depreciation and amortization (Note 5, 6 and 7) | |||||||||||||||||||||||
Operating loss | ( | ( | |||||||||||||||||||||
Finance income, net (Note 9) | ( | ( | |||||||||||||||||||||
Other income | ( | ( | |||||||||||||||||||||
Loss before income taxes | ( | ( | |||||||||||||||||||||
Income tax expense | |||||||||||||||||||||||
Net loss for the periods | ( | ( | |||||||||||||||||||||
Other comprehensive income | |||||||||||||||||||||||
| Item that may be reclassified subsequently to income: | |||||||||||||||||||||||
Exchange gain on translation of foreign operations | ( | ( | |||||||||||||||||||||
Comprehensive loss | ( | ( | |||||||||||||||||||||
Loss per share - basic and diluted | ( | ( | |||||||||||||||||||||
Weighted average number of common shares outstanding - basic and diluted (Note 12) | |||||||||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.
2
| DOCEBO INC. | ||
UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY | ||
| (expressed in thousands of United States dollars, except number of shares) | ||
| Common shares | Contributed surplus | Accumulated other comprehensive income | Deficit | Total | |||||||||||||||||||||||||||||||
| # | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Balance, December 31, 2020 | ( | ||||||||||||||||||||||||||||||||||
Exercise of stock options (Note 11) | ( | — | — | ||||||||||||||||||||||||||||||||
Share-based compensation (Note 10) | — | — | — | — | |||||||||||||||||||||||||||||||
| Comprehensive loss | — | — | — | ( | ( | ||||||||||||||||||||||||||||||
Balance, March 31, 2021 | ( | ||||||||||||||||||||||||||||||||||
Balance, December 31, 2021 | ( | ||||||||||||||||||||||||||||||||||
Exercise of stock options (Note 10 and 11) | ( | — | — | ||||||||||||||||||||||||||||||||
Share-based compensation (Note 11) | — | — | — | — | |||||||||||||||||||||||||||||||
Share issuance under ESPP (Note 10 and 11) | ( | — | — | ||||||||||||||||||||||||||||||||
| Comprehensive loss | — | — | — | ( | ( | ||||||||||||||||||||||||||||||
Balance, March 31, 2022 | ( | ||||||||||||||||||||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.
3
| DOCEBO INC. | ||
UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS | ||
| (expressed in thousands of United States dollars) | ||
Three months ended March 31, | |||||||||||
| 2022 | 2021 | ||||||||||
| $ | $ | ||||||||||
| Cash flows (used in) from operating activities | |||||||||||
Net loss | ( | ( | |||||||||
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||
| Depreciation and amortization | |||||||||||
| Share-based compensation | |||||||||||
Unrealized foreign exchange loss | |||||||||||
Income tax expense | |||||||||||
Finance income, net | ( | ( | |||||||||
| Changes in non-cash working capital items: | |||||||||||
| Trade and other receivables | ( | ||||||||||
| Prepaids and deposits | ( | ( | |||||||||
| Contract costs | ( | ( | |||||||||
| Trade and other payables | |||||||||||
| Employee benefit obligations | |||||||||||
| Deferred revenue | |||||||||||
Cash used in operating activities | ( | ( | |||||||||
Cash flows used in investing activities | |||||||||||
| Purchase of property and equipment | ( | ( | |||||||||
| Acquisition of business, net of cash acquired | ( | ||||||||||
Cash used in investing activities | ( | ( | |||||||||
| Cash flows (used in) from financing activities | |||||||||||
| Payments received on net investment in finance lease | |||||||||||
| Repayment of lease obligations | ( | ( | |||||||||
| Interest received | |||||||||||
| Proceeds from exercise of stock options | |||||||||||
| Proceeds from share issuance under ESPP | |||||||||||
| Repayment of borrowings | ( | ||||||||||
Cash from (used in) financing activities | ( | ||||||||||
Net change in cash and cash equivalents during the period | ( | ( | |||||||||
| Effect of foreign exchange on cash and cash equivalents | ( | ||||||||||
Cash and cash equivalents, beginning of the period | |||||||||||
Cash and cash equivalents, end of the period | |||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.
4
| DOCEBO INC. | ||
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS | ||
March 31, 2022 | ||
| (expressed in thousands of US dollars, except share amounts) | ||
| 1 | |||||
Docebo Inc. (the “Company” or “Docebo”) is a provider of cloud-based learning management systems. The Company was incorporated on April 21, 2016 under the laws of the Province of Ontario. The Company’s head office is located at Suite 701, 366 Adelaide Street West, Toronto, Canada, M5V 1R9.
The Company’s shares are listed on both the Toronto Stock Exchange (“TSX”), as of October 8, 2019, and the Nasdaq Global Select Market (“Nasdaq”), as of December 3, 2020, under the stock symbol “DCBO”.
The Company has the following subsidiaries:
| Entity name | Country | Ownership percentage March 31, 2022 | Ownership percentage December 31, 2021 | ||||||||||||||
| % | % | ||||||||||||||||
| Docebo S.p.A | Italy | ||||||||||||||||
| Docebo NA, Inc. | United States | ||||||||||||||||
| Docebo EMEA FZ-LLC | Dubai | ||||||||||||||||
| Docebo UK Limited | England | ||||||||||||||||
| Docebo France Société par Actions Simplifiée (“Docebo France”) | France | ||||||||||||||||
| Docebo DACH GmbH (“Docebo Germany”) | Germany | ||||||||||||||||
Docebo Australia Pty Ltd1 ("Docebo Australia") | Australia | ||||||||||||||||
| 2 | |||||
Statement of compliance
These unaudited condensed consolidated interim financial statements (“financial statements”) have been prepared by management using the same accounting policies and methods as those used in the Company’s consolidated financial statements for the year ended December 31, 2021. These unaudited condensed consolidated interim financial statements have been prepared in compliance with IAS 34 – Interim Financial Reporting. Accordingly, certain disclosures normally included in annual financial statements prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS”) have been omitted or condensed. These unaudited condensed consolidated interim financial statements should be read in conjunction with the Company’s consolidated financial statements for the year ended December 31, 2021.
These financial statements were approved and authorized for issuance by the Board of Directors of the Company on May 11, 2022.
Use of estimates, assumptions and judgments
The preparation of these financial statements in conformity with IFRS requires management to make estimates, assumptions and judgments that affect the application of accounting policies and the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the period. Actual results may differ from those estimates.
5
DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
March 31, 2022
(expressed in thousands of US dollars, except share amounts)
Estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
The impact of the novel coronavirus (“COVID-19”) pandemic, with its combined health toll and sharp decline in global economic output, is unprecedented and the full extent of the impact will depend on future developments. These developments are highly uncertain and cannot be accurately predicted, including new information which may emerge concerning its severity, its duration and actions by government authorities to contain the outbreak or manage its impact. The extent of the impact of COVID-19 and measures taken to contain the virus on our results of operations and overall financial performance remains uncertain.
| 3 | |||||
| 4 | |||||
The Company’s trade and other receivables as at March 31, 2022 and December 31, 2021 include the following:
2022 | 2021 | ||||||||||
| $ | $ | ||||||||||
| Trade receivables | |||||||||||
| Accrued revenues | |||||||||||
| Tax credits receivable | |||||||||||
| Other receivables | |||||||||||
Included in trade receivables is a loss allowance of $1,051 as at March 31, 2022 and $1,007 as at December 31, 2021.
| 5 | |||||
The Company’s right-of-use assets by class of assets are as follows:
| Premises | Others | Total | |||||||||||||||
| $ | $ | $ | |||||||||||||||
| Costs | |||||||||||||||||
Balance – December 31, 2021 | |||||||||||||||||
| Additions | |||||||||||||||||
| Effects of foreign exchange | ( | ( | ( | ||||||||||||||
Balance – March 31, 2022 | |||||||||||||||||
6
DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
March 31, 2022
(expressed in thousands of US dollars, except share amounts)
| Premises | Others | Total | |||||||||||||||
| Accumulated amortization | |||||||||||||||||
Balance – December 31, 2021 | |||||||||||||||||
| Amortization | |||||||||||||||||
| Effects of foreign exchange | ( | ( | ( | ||||||||||||||
Balance – March 31, 2022 | |||||||||||||||||
| Carrying value | |||||||||||||||||
Net balance – December 31, 2021 | |||||||||||||||||
Net balance – March 31, 2022 | |||||||||||||||||
The Company’s lease obligations are as follows:
2022 | ||||||||||||||
| $ | ||||||||||||||
| Balance – December 31, 2021 | ||||||||||||||
| Additions | ||||||||||||||
| Interest accretion | ||||||||||||||
| Lease repayments | ( | |||||||||||||
| Effects of foreign exchange | ( | |||||||||||||
Balance – March 31, 2022 | ||||||||||||||
| Current | ||||||||||||||
| Non-current | ||||||||||||||
7
DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
March 31, 2022
(expressed in thousands of US dollars, except share amounts)
| 6 | |||||
| Furniture and office equipment | Leasehold improvements | Land and Building | Total | ||||||||||||||||||||
| $ | $ | $ | $ | ||||||||||||||||||||
| Cost | |||||||||||||||||||||||
Balance – December 31, 2021 | |||||||||||||||||||||||
| Additions | |||||||||||||||||||||||
| Effects of foreign exchange | ( | ( | ( | ( | |||||||||||||||||||
Balance – March 31, 2022 | |||||||||||||||||||||||
| Accumulated depreciation | |||||||||||||||||||||||
Balance – December 31, 2021 | |||||||||||||||||||||||
| Depreciation | |||||||||||||||||||||||
| Effects of foreign exchange | ( | ( | ( | ( | |||||||||||||||||||
Balance – March 31, 2022 | |||||||||||||||||||||||
| Carrying value | |||||||||||||||||||||||
Balance – December 31, 2021 | |||||||||||||||||||||||
Balance – March 31, 2022 | |||||||||||||||||||||||
| 7 | |||||
| Acquired | ||||||||||||||||||||||||||
| Customer relationships | Technology | Trademarks | Total | |||||||||||||||||||||||
| $ | $ | $ | $ | |||||||||||||||||||||||
| Cost | ||||||||||||||||||||||||||
Balance – December 31, 2021 | ||||||||||||||||||||||||||
| Effects of foreign exchange | ( | ( | ( | ( | ||||||||||||||||||||||
Balance – March 31, 2022 | ||||||||||||||||||||||||||
| Accumulated amortization | ||||||||||||||||||||||||||
Balance – December 31, 2021 | ||||||||||||||||||||||||||
| Amortization | ||||||||||||||||||||||||||
| Effects of foreign exchange | ( | ( | ( | |||||||||||||||||||||||
Balance – March 31, 2022 | ||||||||||||||||||||||||||
| Carrying value | ||||||||||||||||||||||||||
Balance – December 31, 2021 | ||||||||||||||||||||||||||
Balance – March 31, 2022 | ||||||||||||||||||||||||||
8
DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
March 31, 2022
(expressed in thousands of US dollars, except share amounts)
| 8 | |||||
| $ | |||||
Balance – December 31, 2021 | |||||
| Additions | |||||
| Effects of foreign exchange | ( | ||||
Balance – March 31, 2022 | |||||
On January 21, 2022, the Company acquired all of the issued and outstanding shares of Skillslive for total consideration, including a working capital adjustment, of $1,071 . The acquisition of Skillslive will contribute to the expansion of the Company’s footprint in Australia and accelerate time-to-market by immediately adding specialized talent and infrastructure in the Asia-Pacific (“APAC”) region.
| 9 | |||||
Credit Facility
On June 1, 2021, the Company terminated the $15,000 committed revolving term credit facility (the “Credit Facility”) it secured from the Toronto-Dominion Bank on July 25, 2019 and repaid all accrued and unpaid interest. Unamortized financing costs of $64 were derecognized and expensed to finance expense during the second quarter of 2021. Prior to termination, the balance drawn on the facility was $nil .
Finance income, net
Finance income for the three months ended March 31, 2022 and 2021 is comprised of:
Three months ended March 31, | |||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||
| $ | $ | ||||||||||||||||||||||
| Interest on contingent consideration | |||||||||||||||||||||||
| Interest on lease obligations | |||||||||||||||||||||||
| Interest and amortization of deferred financing costs on credit facility | |||||||||||||||||||||||
| Interest income | ( | ( | |||||||||||||||||||||
| ( | ( | ||||||||||||||||||||||
9
DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
March 31, 2022
(expressed in thousands of US dollars, except share amounts)
| 10 | |||||
| Authorized: | |||||||||||
| Unlimited common shares with no par value | |||||||||||
| Issued and outstanding: | |||||||||||
Number of shares | Amount | ||||||||||
| # | $ | ||||||||||
Balance – December 31, 2021 | |||||||||||
| Stock option exercise | |||||||||||
| Share issuance under ESPP | |||||||||||
Balance – March 31, 2022 | |||||||||||
| 11 | |||||
Three months ended March 31, | |||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||
| $ | $ | ||||||||||||||||||||||
| Stock options | |||||||||||||||||||||||
| DSUs | |||||||||||||||||||||||
| RSUs | |||||||||||||||||||||||
| ESPP | |||||||||||||||||||||||
There were no
The changes in the number of stock options during the three months ended March 31, 2022 and 2021 were as follows:
2022 | 20211 | ||||||||||||||||||||||
| Number of options | Weighted average exercise price | Number of options | Weighted average exercise price | ||||||||||||||||||||
| # | C$ | # | C$ | ||||||||||||||||||||
| Options outstanding – January 1 | |||||||||||||||||||||||
Options granted1 | |||||||||||||||||||||||
| Options forfeited | ( | ||||||||||||||||||||||
| Options exercised | ( | ( | |||||||||||||||||||||
Options outstanding – March 31 | |||||||||||||||||||||||
Options exercisable – March 31 | |||||||||||||||||||||||
1 In March 2021, the Company granted stock options to certain executives. Subsequently, the Company identified an error in determining the expected life and volatility inputs used in the Black-Scholes pricing model to calculate the fair value of options, which led to the Company determining that 63,992 excess options were granted in March 2021 to six senior executives (the “Awardees”). The granting of excess options was immaterial to the Company but the error resulted in an award of options to the Awardees that was not reasonable and appropriate to grant. During 2021, the Company amended and restated the option award agreements for those affected Awardees to reflect the issuance of the appropriate number of options.
10
DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
March 31, 2022
(expressed in thousands of US dollars, except share amounts)
The following table is a summary of the Company’s stock options outstanding as at March 31, 2022:
| Options outstanding | Options exercisable | |||||||||||||||||||||||||
| Exercise price range | Number outstanding | Weighted average remaining contractual life (years) | Exercise price range | Number exercisable | ||||||||||||||||||||||
| C$ | # | # | C$ | # | ||||||||||||||||||||||
The following table is a summary of the Company’s stock options outstanding as at March 31, 2021:
| Options outstanding | Options exercisable | |||||||||||||||||||||||||
| Exercise price range | Number outstanding | Weighted average remaining contractual life (years) | Exercise price range | Number exercisable | ||||||||||||||||||||||
| C$ | # | # | C$ | # | ||||||||||||||||||||||
The weighted average fair value of share options granted during the three months ended March 31, 2022 and 2021 was estimated at the date of grant using the Black-Scholes option pricing model using the following inputs:
2022 | 2021 | ||||||||||
| C$ | C$ | ||||||||||
| Weighted average stock price valuation | $ | $ | |||||||||
| Weighted average exercise price | $ | $ | |||||||||
| Risk-free interest rate | % | % | |||||||||
| Expected life in years | |||||||||||
| Expected dividend yield | % | % | |||||||||
| Volatility | % | % | |||||||||
| Weighted average fair value of options issued | $ | $ | |||||||||
DSUs
The following table presents information concerning the number of DSUs granted by the Company:
| # | |||||
DSUs – December 31, 2021 | |||||
Granted (at C$ | |||||
DSUs - March 31, 2022 | |||||
11
DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
March 31, 2022
(expressed in thousands of US dollars, except share amounts)
RSUs
The following table presents information concerning the number of RSUs granted by the Company:
| # | |||||
RSUs – December 31, 2021 | |||||
Granted (at C$ | |||||
Forfeited (at $ | ( | ||||
RSUs - March 31, 2022 | |||||
| 12 | |||||
The Company has three categories of potentially dilutive securities outstanding: stock options, DSUs and RSUs. All potentially dilutive securities have been excluded from the calculation of diluted loss per share for the periods in which the Company is in a net loss position. Including the dilutive securities in these periods would be anti-dilutive; therefore, basic and diluted number of shares used in the calculation is the same for the periods presented.
The weighted average outstanding number and type of securities that could potentially dilute basic net income per share in the future but would have decreased the loss per share (anti-dilutive) for the periods in which the Company is in a net loss position are as follows:
Three months ended March 31, | |||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||
| # | # | ||||||||||||||||||||||
| Stock options | |||||||||||||||||||||||
| DSUs | |||||||||||||||||||||||
| RSUs | |||||||||||||||||||||||
| 13 | |||||
Disaggregated revenue
The Company derives its revenues from two main sources, subscription to its SaaS application, and professional services revenue, which includes services such as initial implementation, project management, and training.
The following table represents disaggregation of revenue for the three months ended March 31:
Three months ended March 31, | |||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||
| $ | $ | ||||||||||||||||||||||
| Subscription revenue | |||||||||||||||||||||||
| Professional services | |||||||||||||||||||||||
12
DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
March 31, 2022
(expressed in thousands of US dollars, except share amounts)
| 14 | |||||
The following table represents cost of revenue for the three months ended March 31:
Three months ended March 31, | |||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||
| $ | $ | ||||||||||||||||||||||
| Employee salaries and benefits | |||||||||||||||||||||||
| Web hosting fees | |||||||||||||||||||||||
| Third party service fees | |||||||||||||||||||||||
| Other | |||||||||||||||||||||||
| 15 | |||||
Employee compensation costs were included in the following expenses for the three months ended March 31:
Three months ended March 31, | |||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||
| $ | $ | ||||||||||||||||||||||
| Cost of revenue | |||||||||||||||||||||||
| General and administrative | |||||||||||||||||||||||
| Sales and marketing | |||||||||||||||||||||||
| Research and development | |||||||||||||||||||||||
| 16 | |||||
Key management personnel are those persons having the authority and responsibility for planning, directing and controlling activities of the Company, directly or indirectly, including the Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, Chief Technology Officer, Chief Corporate Development Officer and Chief Human Resource Officer and Directors.
Compensation expense for the Company’s key management personnel for the three months ended March 31, 2022 and 2021 is as follows:
Three months ended March 31, | |||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||
| $ | $ | ||||||||||||||||||||||
| Salaries and benefits | |||||||||||||||||||||||
| Share-based compensation | |||||||||||||||||||||||
| 17 | |||||
13
DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
March 31, 2022
(expressed in thousands of US dollars, except share amounts)
Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from deposits with banks and outstanding receivables. The Company trades only with recognized, creditworthy third parties. Due to the Company’s diversified customer base, there is no particular concentration of credit risk related to the Company’s trade and other receivables. Trade and other receivables are monitored on an ongoing basis to ensure timely collection of amounts. Potential effects from COVID-19 on the Company’s credit risk have been considered and have resulted in increases to its allowances for expected credit losses on customer balances. The Company continues its assessment given the fluidity of COVID-19’s global impact.
The carrying values of cash and cash equivalents, trade and other receivables, trade and other payables and borrowings approximate fair values due to the short-term nature of these items or being carried at fair value or, for borrowings, the interest rates charged approximate current market rates. The risk of material change in fair value is not considered to be significant. The Company does not use derivative financial instruments to manage this risk.
Contingent consideration is classified as a Level 3 financial instrument. The fair value of the contingent consideration was calculated using discounted cash flows. During the three months ended March 31, 2022, there were no transfers of amounts between levels in the fair value hierarchy.
| 18 | |||||
The following tables present details on revenues derived in the following geographical locations for the three months ended March 31, 2022 and 2021.
Three months ended March 31, | |||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||
| $ | $ | ||||||||||||||||||||||
| North America | |||||||||||||||||||||||
Rest of World | |||||||||||||||||||||||
14
Exhibit 99.2
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2022
As used in this management’s discussion and analysis of financial condition and results of operations (“MD&A”), unless the context indicates or requires otherwise, all references to the “Company”, “Docebo”, “we”, “us” or “our” refer to Docebo Inc., together with our subsidiaries, on a consolidated basis as constituted on March 31, 2022.
This MD&A for the three months ended March 31, 2022 and 2021 should be read in conjunction with the Company’s unaudited condensed consolidated interim financial statements and accompanying notes thereto for the three months ended March 31, 2022 and 2021, and the Company's audited annual consolidated financial statements and accompanying notes thereto for the year ended December 31, 2021. The financial information presented in this MD&A is derived from the Company’s unaudited condensed consolidated interim financial statements for the three months ended March 31, 2022 and 2021 which have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). All amounts are in thousands of United States dollars except where otherwise indicated.
This MD&A is dated as of May 11, 2022.
Forward-looking Information
This MD&A contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking information”) within the meaning of applicable securities laws. Forward-looking information may relate to our future financial outlook and anticipated events or results and may include information regarding our financial position, business strategy, the ongoing impact of COVID-19 on our business, growth strategies, addressable markets, budgets, operations, financial results, taxes, dividend policy, plans and objectives. Particularly, information regarding our expectations of future results, performance, achievements, prospects or opportunities or the markets in which we operate is forward-looking information.
In some cases, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects”, “is expected”, “an opportunity exists”, “budget”, “scheduled”, “estimates”, “outlook”, “forecasts”, “projection”, “prospects”, “strategy”, “intends”, “anticipates”, “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or, “will”, “occur” or “be achieved”, and similar words or the negative of these terms and similar terminology. In addition, any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates and projections regarding future events or circumstances.
This forward-looking information includes, but is not limited to, statements regarding the Company’s business; future financial position and business strategy; the learning management industry; our growth rates and growth strategies; addressable markets for our solutions; the achievement of advances in and expansion of our platform; expectations regarding our revenue and the revenue generation potential of our platform and other products; our business plans and strategies; and our competitive position in our industry. This forward-looking information is based on our opinions, estimates and assumptions in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we currently believe are appropriate and reasonable in the circumstances. Despite a careful process to prepare and review the forward-looking information, there can be no assurance that the underlying opinions, estimates and assumptions will prove to be correct. Certain assumptions include: our ability to build our market share and enter new markets and industry verticals; our ability to attract and retain key personnel; our ability to maintain and expand geographic scope; our ability to execute on our expansion plans; our ability to continue investing in infrastructure to support our growth; our ability to obtain and maintain existing financing on acceptable terms; our ability to execute on profitability initiatives; currency exchange and interest rates; the impact of inflation; the impact of competition; the effectiveness of mitigation strategies undertaken with respect to COVID-19, and the severity, duration and impacts of COVID-19 on the economy and our business, which is highly uncertain and cannot reasonably be predicted; our
1
ability to respond to the changes and trends in our industry or the global economy; and the changes in laws, rules, regulations, and global standards are material factors made in preparing forward-looking information and management’s expectations.
Forward-looking information is necessarily based on a number of opinions, estimates and assumptions that, while considered by the Company to be appropriate and reasonable as of the date of this MD&A, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to:
•the Company’s ability to execute its growth strategies;
•the impact of changing conditions in the global corporate e-learning market;
•increasing competition in the global corporate e-learning market in which the Company operates;
•fluctuations in currency exchange rates and volatility in financial markets;
•the extent of the impact of COVID-19 on our results of operations and overall financial performance;
•changes in the attitudes, financial condition and demand of our target market;
•developments and changes in applicable laws and regulations; and
•such other factors discussed in greater detail under the “Risk Factors” section of our Annual Information Form dated March 9, 2022 (“AIF”), which is available under our profile on SEDAR at www.sedar.com.
If any of these risks or uncertainties materialize, or if the opinions, estimates or assumptions underlying the forward-looking information prove incorrect, actual results or future events might vary materially from those anticipated in the forward-looking information. The opinions, estimates or assumptions referred to above and described in greater detail in “Summary of Factors Affecting our Performance” and in the “Risk Factors” section of our AIF, should be considered carefully by prospective investors.
Although we have attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other risk factors not presently known to us or that we presently believe are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. No forward-looking statement is a guarantee of future results. Accordingly, you should not place undue reliance on forward-looking information, which speaks only as of the date made. The forward-looking information contained in this MD&A represents our expectations as of the date specified herein, and are subject to change after such date. However, we disclaim any intention or obligation or undertaking to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable securities laws.
All of the forward-looking information contained in this MD&A is expressly qualified by the foregoing cautionary statements.
Additional information relating to Docebo, including our AIF, can be found on SEDAR at www.sedar.com.
Overview
At Docebo, our mission is to redefine the way enterprises, including their internal and external workforces, partners and customers, learn by applying new technologies to the traditional corporate Learning Management System (“LMS”) market. Founded in 2005, we provide an easy-to-use, highly configurable and affordable learning platform with the end-to-end capabilities and critical functionality needed to train internal and external workforces, partners and customers. Our solution allows our customers to take control of their desired training strategies and retain institutional knowledge, while providing efficient course delivery, tracking of learning progress, advanced reporting tools and analytics. Our robust platform helps our customers centralize a broad range of learning materials from peer enterprises and learners into one LMS to expedite and enrich the learning process, increase productivity and grow teams uniformly.
2
Our platform is now used by more than 2,900 companies of all sizes, providing access to learners situated around the world in a variety of languages. Our clients range from select small local businesses, with a focus on mid-sized enterprises, to large multi-nationals, including service, financial, technology and resource-based companies and consulting firms. Our platform is sold primarily through a direct sales force with offices in Toronto, Canada, Athens, Georgia (USA), Biassono, Italy, London, United Kingdom, Paris, France, Frankfurt, Germany and Melbourne, Australia. We also have some relationships with resellers and other channel partners, such as human resource and payroll services providers.
Docebo offers a learning suite which currently includes: (i) “Docebo Learn LMS”, (ii) “Docebo Shape”, (iii) “Docebo Content”, (iv) “Docebo Learning Impact”, (v) “Docebo Learning Analytics”, (vi) “Docebo Connect” and (vii) “Docebo Flow”.
•Docebo Learn LMS is a cloud-based learning platform that allows learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning, to multiple internal, external and blended audiences.
•Docebo Shape is an AI-based learning content creation tool that enables learning administrators to turn internal and external resources into engaging, multilingual microlearning content to share across their business in minutes, without needing months to master the tool.
•Docebo Content allows learning administrators to unlock the industry’s best-learning content and get high-quality, off-the-shelf learning content in front of your learners. Learning administrators can select the most impactful e-learning content by partnering with a Docebo Content specialist to help curate the right resources.
•Docebo Learning Impact is a learning measurement tool that enables learning administrators to prove and improve the impact of their training programs and validate their company’s investment in learning with optimized questionnaires, learning benchmarks and actionable next steps.
•Docebo Learning Analytics allows learning administrators to prove their learning programs are powering their business; connecting learning data to business results.
•Docebo Connect enables learning administrators to seamlessly connect Docebo to any custom tech stack, making integrations faster and more effective.
•Docebo Flow is a product that allows businesses to directly inject learning into the flow of work, helping organizations to create an ‘always-on’ learning culture.
Additional modules can also be purchased with the LMS and the Suite including: “Docebo for Salesforce”, “Docebo Embed (OEM)”, “Docebo Mobile App Publisher”, “Docebo Extended Enterprise”, and “Docebo Discover, Coach & Share”. Docebo for Salesforce is a native integration that leverages Salesforce’s API and technology architecture to produce a learning experience that remains uniform no matter the use-case. Docebo Embed (OEM) eliminates disjointed learner experiences, long development cycles and ineffective partner models by allowing original equipment manufacturers (“OEMs”) to embed and re-sell Docebo as a part of their software, including HCM, risk management and retail/hospitality SaaS product suites. Docebo’s Mobile App Publisher product allows companies to create their own branded version of the award-winning “Docebo Go.Learn” mobile learning application and publish it as their own in Apple’s App Store, the Google Play Store or in their own Apple Store for Enterprise. Docebo Extended Enterprise breeds customer education, partner enablement, and retention by allowing customers to train multiple external audiences with a single LMS solution. Lastly, Docebo Discover, Coach & Share enhances the learning experience by going beyond the limits of formal training by bringing social learning into their LMS to create a culture of social learning.
We generate revenue primarily from the sale of our platform, which is typically sold on the basis of an annual subscription fee and prepaid on a quarterly or annual basis. We offer our customers the flexibility to choose annual or multi-year contract terms, with the majority of our enterprise customers choosing three years. This results in a
3
relatively smooth revenue curve with good visibility into near-term revenue growth. We typically enter into subscription agreements with our customers, with pricing based on the number of active users in a measured time period, generally one month, and the number of modules requested by the customer. Our goal is to continue to grow revenues arising from our existing customer base as well as adding new subscription customers to our platform. Our business does not have significant seasonal attributes, although historically the sales in the fourth quarter have tended to be slightly stronger than the first three. The Company operates on a global basis and for this reason has decided to report its consolidated financial results in U.S. dollars notwithstanding that the Company’s functional currency is the Canadian dollar. The Company does not currently hedge its exposure to currencies different than its functional currency.
The Company’s shares are listed under the symbol “DCBO” on both the Toronto Stock Exchange, as of October 8, 2019, following the completion of its public offering in Canada (the “TSX IPO”) and the Nasdaq Global Select Market (the “Nasdaq”), as of December 3, 2020, following the completion of its initial public offering in the United States (the “Nasdaq IPO” and together with the TSX IPO, the “IPOs”).
Non-IFRS Measures and Reconciliation of Non-IFRS Measures
This MD&A makes reference to certain non-IFRS measures including key performance indicators used by management and typically used by our competitors in the software-as-a-service (“SaaS”) industry. These measures are not recognized measures under IFRS and do not have a standardized meaning prescribed by IFRS and are therefore not necessarily comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of our results of operations from management’s perspective. Accordingly, these measures should not be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS. These non-IFRS measures are used to provide investors with alternative measures of our operating performance and liquidity and thus highlight trends in our business that may not otherwise be apparent when relying solely on IFRS measures. We also believe that securities analysts, investors and other interested parties frequently use non-IFRS measures, including SaaS industry metrics, in the evaluation of companies in the SaaS industry. Management also uses non-IFRS measures to facilitate operating performance comparisons from period to period, the preparation of annual operating budgets and forecasts and to determine components of executive compensation. The non-IFRS measures referred to in this MD&A include “Annual Recurring Revenue”, “Adjusted EBITDA”, “Working Capital” and “Free Cash Flow”.
Key Performance Indicators
We recognize subscription revenues ratably over the term of the subscription period under the provisions of our agreements with customers. The terms of our agreements, combined with high customer retention rates, provides us with a significant degree of visibility into our near-term revenues. Management uses a number of metrics, including the ones identified below, to measure the Company’s performance and customer trends, which are used to prepare financial plans and shape future strategy. Our key performance indicators may be calculated in a manner different than similar key performance indicators used by other companies.
Annual Recurring Revenue. We define Annual Recurring Revenue as the annualized equivalent value of the subscription revenue of all existing contracts (including OEM contracts) as at the date being measured, excluding non-recurring revenues from implementation, support and maintenance fees. Our customers generally enter into one to three year contracts which are non-cancellable or cancellable with penalty. Accordingly, our calculation of Annual Recurring Revenue assumes that customers will renew the contractual commitments on a periodic basis as those commitments come up for renewal. Subscription agreements may be subject to price increases upon renewal reflecting both inflationary increases and the additional value provided by our solutions. In addition to the expected increase in subscription revenue from price increases over time, existing customers may subscribe for additional features, learners or services during the term. We believe that this measure provides a fair real-time measure of performance in a subscription-based environment. Annual Recurring Revenue provides us with visibility for consistent and predictable growth to our cash flows. Our strong total revenue growth coupled with increasing Annual Recurring Revenue indicates the continued strength in the expansion of our business and will continue to be our focus on a go-forward basis.
4
Annual Recurring Revenue was as follows as at March 31:
2022 | 2021 | Change | Change % | |||||||||||
| Annual Recurring Revenue (in millions of US dollars) | 129.3 | 83.4 | 45.9 | 55.0% | ||||||||||
Adjusted EBITDA
EBITDA is defined as net loss before amortization and depreciation expenses, net finance (income) expense, and income taxes.
Adjusted EBITDA is defined as net loss excluding taxes (if applicable), net finance (income) expense, depreciation and amortization, loss on disposal of assets (if applicable), share-based compensation, foreign exchange gains and losses, acquisition related compensation and transaction related expenses.
The IFRS measure most directly comparable to Adjusted EBITDA presented in our financial statements is net loss.
The following table reconciles Adjusted EBITDA to net loss for the periods indicated:
Three months ended March 31, | |||||||||||||||||
2022 | 2021 | ||||||||||||||||
| $ | $ | ||||||||||||||||
Net loss for the period | (6,959) | (5,644) | |||||||||||||||
Finance income, net(1) | (19) | (2) | |||||||||||||||
Depreciation and amortization(2) | 580 | 474 | |||||||||||||||
Income tax expense | 129 | 43 | |||||||||||||||
| EBITDA | (6,269) | (5,129) | |||||||||||||||
Share-based compensation(3) | 1,215 | 378 | |||||||||||||||
Other income(4) | (21) | (21) | |||||||||||||||
Foreign exchange loss(5) | 3,391 | 1,951 | |||||||||||||||
Acquisition related compensation(6) | 295 | 102 | |||||||||||||||
Transaction related expenses(7) | 101 | 246 | |||||||||||||||
| Adjusted EBITDA | (1,288) | (2,473) | |||||||||||||||
Notes:
(1)Finance income, net, for the three months ended March 31, 2022 is primarily related to interest income earned on the net proceeds from the IPOs as the funds are held within short-term investments in highly liquid marketable securities which is offset by interest expenses incurred on the credit facility, lease obligations and contingent consideration.
(2)Depreciation and amortization expense is primarily related to depreciation expense on right-of-use assets (“ROU assets”), property and equipment and acquired intangible assets.
(3)These expenses represent non-cash expenditures recognized in connection with the issuance of share-based compensation to our employees and directors and cash payroll taxes paid on gains earned by option holders when stock options are exercised.
(4)Other income is primarily comprised of rental income from subleasing office space.
(5)These non-cash gains and losses relate to foreign exchange loss.
(6)These costs represent acquisition related retention incentives associated with the achievement of both yearly performance milestones and continued employment for employees of the acquiree.
(7)These expenses relate to professional, legal, consulting, accounting and other fees related to acquisition activities and the Nasdaq IPO in December 2020 that would otherwise have not been incurred and are not considered an expense indicative of continuing operations.
See “Liquidity, Capital Resources and Financing - Working Capital” and “Liquidity, Capital Resources and Financing - Free Cash Flow” in this MD&A for an explanation of Working Capital and Free Cash Flow (and, in the case of Free Cash Flow, a reconciliation of such measure to the most directly comparable IFRS measure presented in our financial statements).
5
Summary of Factors Affecting Our Performance
We believe that the growth and future success of our business depends on many factors, including those described below. While each of these factors presents significant opportunities for our business, they also pose important challenges, some of which are discussed below and in the “Risk Factors” section of the AIF.
Market adoption of our SaaS platform
We intend to continue to drive adoption of our SaaS platform by scaling our solutions to meet the needs of both new and existing customers. We believe that there is significant potential to increase penetration of our total addressable market and attract new customers. We plan to do this by further developing our products and services as well as continuing to invest in marketing strategies tailored to attract new businesses to our platform, both in our existing geographies and new markets around the world. We plan to continue to invest in our platform to expand our customer base and drive market adoption. The success of our operations may fluctuate as we make these investments.
Up-selling with existing customers
Our existing customers represent a significant opportunity to up-sell additional functionality with limited incremental sales and marketing expense. We plan to continually invest in product development and sales and marketing to add additional solutions to our platform as well as increase the usage and awareness of our platform. Our future revenue growth and our ability to achieve and maintain profitability is dependent upon our ability to maintain existing customer relationships and to continue to expand our customers’ use of our platform.
Scaling our sales and marketing team
Our ability to achieve significant growth in future revenue will largely depend upon the effectiveness of our sales and marketing efforts. The majority of our sales and marketing efforts are accomplished in-house and we believe the strength of our sales and marketing team is critical to our success. We have invested, and intend to continue to invest meaningfully, in the expansion of our sales force and consequently, we anticipate that our headcount will continue to increase as a result of these investments.
Foreign currency
The Company’s functional currency is Canadian dollars, the functional currency for our subsidiaries is the local currency of the country the foreign operation is located in and our presentation currency is the U.S. dollar. Our results of operations are converted from our functional currency to U.S. dollars using the average foreign exchange rates for each period presented. As a result, our results of operations will be adversely impacted by a decrease in the value of the U.S. dollar relative to the Euro and Canadian dollar. See “Risk Factors” section of our Annual Information Form dated March 9, 2022 for a discussion on exchange rate fluctuations and their potential negative effect on our results of operations.
Natural disasters, public health crises, political crises, or other catastrophic events
Natural disasters, such as earthquakes, hurricanes, tornadoes, floods, and other adverse weather and climate conditions; unforeseen public health crises such as the global outbreak of COVID-19, and other pandemics and epidemics; political crises, such as terrorist attacks, war, including the current war in Ukraine, and other political instability; or other catastrophic events, could disrupt our operations in any of our offices or the operations of one or more of our third-party providers and vendors. To the extent any of these events occur, our business and results of operations could be adversely affected. For example, the outbreak of COVID-19 in early 2020 may have had and could continue to have an adverse effect our employees and customers. However, the impact of COVID-19, with its combined health toll and sharp decline in global economic output, is unprecedented in modern history and the full extent of the impact will depend on future developments. These developments are highly uncertain and cannot be
6
accurately predicted, including new information which may emerge concerning its severity, its duration and actions by government authorities to contain the outbreak or manage its impact. In response to the pandemic, we have modified our business practices with a focus on the health and well-being of our workforce both in Europe and North America which is working remotely where required by local law or regulation and has been, depending on personal preferences and circumstances, provided with the flexibility to continue working remotely when such laws or regulations are lifted. The extent of the impact of COVID-19 and measures taken to contain the virus on our results of operations and overall financial performance remains uncertain.
If we fail to retain key employees or to recruit qualified technical and sales personnel, our business could be harmed.
We believe that our success depends on the continued employment of our senior management and other key employees. In addition, because our future success is dependent on our ability to continue to enhance and introduce new platform features, we are heavily dependent on our ability to attract and retain qualified personnel with the requisite education, background, and industry experience. As we expand our business, our continued success will also depend, in part, on our ability to attract and retain qualified sales, marketing, and operational personnel capable of supporting a larger and more diverse customer base. We and our competitors continue to face significant turnover in our employee base. Qualified individuals are in high demand in our industry, and we may incur significant costs to attract and retain them. The loss of the services of a significant number of our technology or sales personnel could be disruptive to our business development efforts or customer relationships. In addition, if any of our key employees joins a competitor or decides to otherwise compete with us, we may experience a material disruption of our operations and business strategy, which may cause us to lose customers or increase operating expenses and may divert our attention as we seek to recruit replacements for the departed employees. Further, changes we make to our current and future work environments (including in connection with COVID-19, such as remote or in-office environments and health and safety matters) may not meet the needs or expectations of our employees or may be perceived as less favourable compared to other companies’ policies, which could negatively impact our ability to hire and retain qualified personnel. Our future work strategy and continued efforts related to employee onboarding, training and development and retention may not be successful. Further, our future work strategy is continuing to evolve and may not meet the needs of our existing and potential future employees and they may prefer work models offered by other companies.
Key Components of Results of Operations
Docebo has always been operated and managed as a single economic entity, notwithstanding the fact that it has operations in several different countries. There is one management team that directs the activities of all aspects of the Company and it is managed globally through global department heads. As a result, we believe that we have one operating segment, being the consolidated company. Over time, this may change as the Company grows and when this occurs we will reflect the change in our reporting practice.
Revenue
We generate revenue from the following two primary sources:
•Recurring Subscriptions to Our Learning Platform and Related Products. Our customers enter into agreements that provide for recurring subscription fees. The majority of the customer agreements currently being entered into have a term of one to three years and are non-cancellable or cancellable with penalty. We recognize revenue from our OEM partnerships based on the monthly royalty payments earned on the basis of our contractual arrangement. Subscription revenue per contract will vary depending upon the particular products that each customer subscribes for, the number and type of learners intended to utilize the platform and the term of the agreement. Subscription revenue is typically recognized evenly over the enforceable term of a contract, commencing on the in-service date.
•Professional Services. Our customers generally require support in implementing our product and training their learners. This support can include system integration, application integration, learner training and any required process-change analysis. Normally, these services are purchased at the same time as the original
7
customer agreement is completed and while they are usually delivered during the 60-120 days immediately following the effective date of the customer agreement, timing can vary. As a result, unlike the recognition of recurring subscription revenue, the recognition of professional service revenue can be recorded unevenly from period to period. When customer agreements are renewed, there is not typically a need for additional professional services so as overall revenue increases over time, the percentage of revenue that is generated from professional services will decrease. Revenues derived from professional services are recognized over the term that the service is provided.
Our agreements generally do not contain any cancellation or refund provisions without penalty, other than in the case of our default.
Cost of Revenue
Cost of revenue is comprised of costs related to provisioning and hosting our learning platform and related products, the delivery of professional services, and customer support. Significant expenses included in cost of revenue include employee salaries and benefits expenses, web hosting fees, third party service fees, and software costs. Share-based compensation and depreciation and amortization is excluded.
Operating Expenses
Our primary operating expenses are as follows:
•General and Administrative. General and administrative expenses consist of employee salaries and benefits expenses for our finance, legal, administrative, human resources, and information technology and security teams. These costs also include consulting and professional service fees, transaction costs related to our acquisitions, software, travel, general office and administrative expenses, credit impairment losses, as well as public company costs including directors and officers liability insurance.
•Sales and Marketing. Sales and marketing expenses are comprised primarily of employee salaries and benefits expenses for our sales and marketing teams, amortization of contract acquisition costs, software, travel and advertising and marketing events. We intend to continue to grow our sales and marketing teams to support our growth strategy. While these expenses may fluctuate from year to year, we expect sales and marketing expenses to increase consistent with our overall growth.
•Research and Development. Research and development expenses are comprised primarily of employee salaries and benefits related to our research and development team (net of tax credits), consulting and professional fees, software, travel and web hosting fees. Our research and development team is focused on both continuous improvement of our existing learning platform, as well as developing new product modules and features. In the immediate future, as Docebo’s growth continues, we expect our research and development costs to increase proportionately, however, over time we believe it is reasonable to expect that they will decline as a percentage of revenue.
•Share-based Compensation. Share-based compensation expenses are comprised of the value of stock options granted to employees expensed over the vesting period of the options, deferred share units (“DSUs”), restricted stock units (“RSUs”) and shares issued pursuant to the Employee Share Purchase Plan (“ESPP”). In addition, the Company’s board of directors may fix, from time to time, a portion of the total compensation (including an annual retainer) paid by the Company to a director in a calendar year for service on the Board (the “Director Fees”) and directors may elect to receive a portion of their total compensation (including cash retainer) in the form of DSUs.
•Foreign Exchange Loss. Foreign exchange loss primarily relates to translation of monetary assets and liabilities denominated in foreign currencies being translated into functional currencies at the foreign exchange rate applicable at the end of each period.
8
•Depreciation and Amortization. Depreciation and amortization expense primarily relates to depreciation on property and equipment, and amortization of ROU assets and intangible assets. Property and equipment are comprised of furniture and office equipment, leasehold improvements and land and building. ROU assets are comprised of capitalized leases. Intangible assets are comprised of acquired intangible assets.
Other Expenses
•Finance Income, net. These costs include accretion of interest on contingent consideration, amortization of financing costs and interest on the credit facility, interest on lease obligations, bank fees less interest income.
•Other Income. Other income is primarily comprised of rental income from subleasing office space.
Results of Operations
The following table outlines our consolidated statements of loss and comprehensive loss for the periods indicated:
Three months ended March 31, | ||||||||||||||||||||
2022 | 2021 | |||||||||||||||||||
| $ | $ | |||||||||||||||||||
| Revenue | 32,055 | 21,742 | ||||||||||||||||||
| Cost of revenue | 6,552 | 3,864 | ||||||||||||||||||
| Gross profit | 25,503 | 17,878 | ||||||||||||||||||
| Operating expenses | ||||||||||||||||||||
| General and administrative | 7,375 | 7,437 | ||||||||||||||||||
| Sales and marketing | 13,747 | 9,119 | ||||||||||||||||||
| Research and development | 6,186 | 4,143 | ||||||||||||||||||
| Share-based compensation | 1,094 | 378 | ||||||||||||||||||
Foreign exchange loss | 3,391 | 1,951 | ||||||||||||||||||
| Depreciation and amortization | 580 | 474 | ||||||||||||||||||
| 32,373 | 23,502 | |||||||||||||||||||
Operating loss | (6,870) | (5,624) | ||||||||||||||||||
Finance income, net, net | (19) | (2) | ||||||||||||||||||
| Other income | (21) | (21) | ||||||||||||||||||
Loss before income taxes | (6,830) | (5,601) | ||||||||||||||||||
Income tax expense | 129 | 43 | ||||||||||||||||||
Net loss for the period | (6,959) | (5,644) | ||||||||||||||||||
Other comprehensive income | ||||||||||||||||||||
| Item that may be reclassified subsequently to income: | ||||||||||||||||||||
Exchange gain on translation of foreign operations | (3,212) | (2,114) | ||||||||||||||||||
Comprehensive loss | (3,747) | (3,530) | ||||||||||||||||||
9
Loss per share - basic and diluted | (0.21) | (0.17) | ||||||||||||||||||
| Weighted average number of common shares outstanding - basic and diluted | 33,017,421 | 32,781,080 | ||||||||||||||||||
Review of Operations for the three months ended March 31, 2022
Revenue
Three months ended March 31, | |||||||||||||||||||||||||||||
2022 | 2021 | Change | Change | ||||||||||||||||||||||||||
| $ | $ | $ | % | ||||||||||||||||||||||||||
| Subscription Revenue | 29,128 | 19,775 | 9,353 | 47 | % | ||||||||||||||||||||||||
| Professional Services | 2,927 | 1,967 | 960 | 49 | % | ||||||||||||||||||||||||
| Total Revenue | 32,055 | 21,742 | 10,313 | 47 | % | ||||||||||||||||||||||||
Revenue increased from $21.7 million, to $32.1 million or 47% for the three months ended March 31, 2022 as compared to the equivalent period in the prior year. The significant revenue increase was primarily attributable to revenue from new customers, as well as up-selling to existing customers, as the number of customers rose from 2,333 as at March 31, 2021 to 2,947 as at March 31, 2022 and the average contract value per customer increased from approximately $36 as at March 31, 2021 to approximately $44 as at March 31, 2022. Average contract value is calculated as total Annual Recurring Revenue divided by the number of active customers (See “Non-IFRS Measures and Reconciliation of Non-IFRS Measures” in this MD&A for an explanation of Annual Recurring Revenue.). All references to the number of customers or companies we serve is based on contracted customers, including underlying OEM customers.
Subscription revenue increased from $19.8 million to $29.1 million or 47% in the first quarter of 2022 as compared to the same quarter in 2021. Revenues from professional services increased by $1.0 million or 49% in the first quarter of 2022 as compared to the same quarter in 2021.
Cost of Revenue
Three months ended March 31, | |||||||||||||||||||||||||||||
2022 | 2021 | Change | Change | ||||||||||||||||||||||||||
| $ | $ | $ | % | ||||||||||||||||||||||||||
| Cost of revenue | 6,552 | 3,864 | 2,688 | 70 | % | ||||||||||||||||||||||||
| Percentage of total revenue | 20.4 | % | 17.8 | % | |||||||||||||||||||||||||
Cost of revenue increased from $3.9 million to $6.6 million or 70% for the three months ended March 31, 2022 as compared to the equivalent period in the prior year. The period over period increase in cost of revenue was primarily driven by the Company’s continued investment in headcount related to customer success and implementation to support the increased delivery of new customer implementations and the roll out of the multi-product strategy. Hosting fees and third party service fees also increased as a result of higher revenues.
10
Gross Profit
Three months ended March 31, | |||||||||||||||||||||||||||||
2022 | 2021 | Change | Change | ||||||||||||||||||||||||||
| $ | $ | $ | % | ||||||||||||||||||||||||||
| Gross profit | 25,503 | 17,878 | 7,625 | 43 | % | ||||||||||||||||||||||||
| Percentage of total revenue | 79.6 | % | 82.2 | % | |||||||||||||||||||||||||
Gross profit, being revenue less cost of revenues, increased from $17.9 million to $25.5 million and decreased from 82.2% of revenue to 79.6% of revenue for the three months ended March 31, 2022 as compared to the three months ended March 31, 2021.
Operating Expenses
Three months ended March 31, | |||||||||||||||||||||||||||||
2022 | 2021 | Change | Change | ||||||||||||||||||||||||||
| $ | $ | $ | % | ||||||||||||||||||||||||||
| General and administrative | 7,375 | 7,437 | (62) | (1) | % | ||||||||||||||||||||||||
| Sales and marketing | 13,747 | 9,119 | 4,628 | 51 | % | ||||||||||||||||||||||||
| Research and development | 6,186 | 4,143 | 2,043 | 49 | % | ||||||||||||||||||||||||
| Share-based compensation | 1,094 | 378 | 716 | 189 | % | ||||||||||||||||||||||||
Foreign exchange loss | 3,391 | 1,951 | 1,440 | 74 | % | ||||||||||||||||||||||||
| Depreciation and amortization | 580 | 474 | 106 | 22 | % | ||||||||||||||||||||||||
| Total operating expenses | 32,373 | 23,502 | 8,871 | 38 | % | ||||||||||||||||||||||||
General and Administrative Expenses
Three months ended March 31, | |||||||||||||||||||||||||||||
2022 | 2021 | Change | Change | ||||||||||||||||||||||||||
| $ | $ | $ | % | ||||||||||||||||||||||||||
| General and administrative | 7,375 | 7,437 | (62) | -1 | % | ||||||||||||||||||||||||
| Percentage of total revenue | 23.0 | % | 34.2 | % | |||||||||||||||||||||||||
General and administrative expenses remained essentially flat at $7.4 million with a slight decrease by 1% for the three months ended March 31, 2022 as compared to the equivalent period in the prior year. The first quarter of 2021 saw higher transaction costs as a result of the NASDAQ IPO. Our general and administrative expenses as a percentage of total revenue decreased from 34.2% to 23.0% for the three months ended March 31, 2021 and March 31, 2022, respectively.
Sales and Marketing Expenses
Three months ended March 31, | |||||||||||||||||||||||||||||
2022 | 2021 | Change | Change | ||||||||||||||||||||||||||
| $ | $ | $ | % | ||||||||||||||||||||||||||
| Sales and marketing | 13,747 | 9,119 | 4,628 | 51 | % | ||||||||||||||||||||||||
| Percentage of total revenue | 42.9 | % | 41.9 | % | |||||||||||||||||||||||||
Sales and marketing expenses increased from $9.1 million to $13.7 million or 51% for the three months ended March 31, 2022 as compared to the equivalent period in the prior year. The increase was due to the Company’s
11
continued focus on growing its subscription revenue in multiple jurisdictions resulting in an increase in headcount and related employee salaries and benefits, as well as an increase in marketing and advertising related spend. The growth in headcount is required to support our sales expansion in new markets, along with managing the growing customer base. We will continue to add staff in this area and incrementally invest in advertising and marketing events for so long as we can efficiently increase our revenue base. Our sales and marketing expenses as a percentage of total revenue increased from 41.9% to 42.9% for the three months ended March 31, 2021 and March 31, 2022, respectively.
Our sales and marketing expenses as a percentage of total revenue will fluctuate quarterly within any given year based on the timing of advertising and marketing events; therefore, expressing sales and marketing expenses as a percentage of total revenue for any given quarter is not necessarily indicative of annual results. As we grow, these fluctuations in sales and marketing expenses as a percentage of total revenue which are attributable to the fluctuations in the timing of advertising and marketing events will moderate. Our medium to long-term expectation for sales and marketing expense as a percentage of total revenue is to be in the 35% to 40% range.
Research and Development Expenses
Three months ended March 31, | |||||||||||||||||||||||||||||
2022 | 2021 | Change | Change | ||||||||||||||||||||||||||
| $ | $ | $ | % | ||||||||||||||||||||||||||
| Research and development | 6,186 | 4,143 | 2,043 | 49 | % | ||||||||||||||||||||||||
| Percentage of total revenue | 19.3 | % | 19.1 | % | |||||||||||||||||||||||||
Research and development expenses increased from $4.1 million to $6.2 million or 49% for the three months ended March 31, 2022 as compared to the equivalent period in the prior year. The increase was driven by a higher number of employees and the related salaries and benefits related thereto. The growth in employee headcount is required to continue to maintain and improve our existing platform and develop new products. On an absolute basis, research and development expenses will continue to grow as the Company maintains its efforts to keep its products at the leading edge of learning technology but will decrease as a percentage of revenue over time. Our research and development expenses as a percentage of total revenue remained essentially flat at 19.3% for the three months ended March 31, 2022 compared to 19.1% in the prior year comparative period.
Share-Based Compensation
Three months ended March 31, | |||||||||||||||||||||||||||||
2022 | 2021 | Change | Change | ||||||||||||||||||||||||||
| $ | $ | $ | % | ||||||||||||||||||||||||||
| Share-based compensation | 1,094 | 378 | 716 | 189 | % | ||||||||||||||||||||||||
| Percentage of total revenue | 3.4 | % | 1.7 | % | |||||||||||||||||||||||||
Share-based compensation expense increased from $378 to $1,094 or 189% for the three months ended March 31, 2022 as compared to the equivalent period in the prior year. The increase was driven by RSUs granted in the fourth quarter of 2021 and stock options and RSUs granted in the first quarter of 2022, along with quarterly DSU expenses. In addition, the Company recognized expenses related to the ESPP, which contributed to the increase in share-based compensation.
12
Foreign Exchange Loss
Three months ended March 31, | |||||||||||||||||||||||||||||
2022 | 2021 | Change | Change | ||||||||||||||||||||||||||
| $ | $ | $ | % | ||||||||||||||||||||||||||
Foreign exchange loss | 3,391 | 1,951 | 1,440 | 74 | % | ||||||||||||||||||||||||
| Percentage of total revenue | 10.6 | % | 9.0 | % | |||||||||||||||||||||||||
Foreign exchange loss primarily relates to translation of monetary assets and liabilities denominated in foreign currencies being translated into functional currencies at the foreign exchange rate applicable at the end of each period. The Company invested the proceeds from the TSX IPO, the bought deal offering completed on August 27, 2020 (the “Bought Deal”) and the Nasdaq IPO in short-term investments denominated in United States dollars. As a result of the movement of the United States dollar in comparison to the Canadian dollar, the Company’s functional currency, an unrealized foreign exchange loss was recorded for the three months ended March 31, 2022 which represents a significant portion of the movement during the periods.
Depreciation and Amortization
Three months ended March 31, | |||||||||||||||||||||||||||||
2022 | 2021 | Change | Change | ||||||||||||||||||||||||||
| $ | $ | $ | % | ||||||||||||||||||||||||||
| Depreciation and amortization | 580 | 474 | 106 | 22 | % | ||||||||||||||||||||||||
| Percentage of total revenue | 1.8 | % | 2.2 | % | |||||||||||||||||||||||||
Depreciation and amortization expense increased from $474 to $580 or 22% for the three months ended March 31, 2022 as compared to the equivalent period in the prior year. The increase in depreciation and amortization expense was primarily due to the purchase of furniture and fixtures and office lease extensions as a result of the continued growth of the Company’s personnel.
Non-operating Items
Three months ended March 31, | |||||||||||||||||||||||||||||
2022 | 2021 | Change | Change | ||||||||||||||||||||||||||
| $ | $ | $ | % | ||||||||||||||||||||||||||
Finance income, net | (19) | (2) | (17) | 850 | % | ||||||||||||||||||||||||
| Other income | (21) | (21) | — | — | % | ||||||||||||||||||||||||
Finance Income, net
Finance income, net increased from $2 to $19 for the three months ended March 31, 2022 as compared to the equivalent period in the prior year. During the first quarter of 2021, the Company incurred interest and amortization of deferred financing costs on the Credit Facility (as defined herein), which was subsequently terminated during the second quarter of 2021 (see “Credit Facility” in this MD&A).
Other Income
Other income is primarily comprised of rental income from subleasing office space and has remained flat period over period.
13
Key Statement of Financial Position Information
March 31, 2022 | December 31, 2021 | Change | Change | |||||||||||
| $ | $ | $ | % | |||||||||||
| Cash and cash equivalents | 211,982 | 215,323 | (3,341) | (2) | % | |||||||||
| Total assets | 273,519 | 268,123 | 5,396 | 2 | % | |||||||||
| Total long-term liabilities | 8,200 | 8,294 | (94) | (1) | % | |||||||||
| Total liabilities | 85,192 | 77,467 | 7,725 | 10 | % | |||||||||
Total Assets
March 31, 2022 compared to December 31, 2021
Total assets increased $5.4 million from December 31, 2021 to March 31, 2022. The increase was driven by trade and other receivables, contract acquisition costs, goodwill and prepaids and deposits. The increase in trade and other receivables and contract acquisition costs of $3.9 million and $3.0 million, respectively, was a result of higher revenue recognized and corresponding capitalized sales commissions. The $1.0 million increase in prepaids and deposits was a result of software purchases made in the first quarter of 2022. The Company also acquired Skillslive Edu Pty Ltd. (“Skillslive”) in the first quarter of 2022, which resulted in an increased goodwill balance by $1.0 million. These increases were offset by a reduction in cash and cash equivalents of $3.3 million used to support operating and investing activities.
Total Liabilities
March 31, 2022 compared to December 31, 2021
Total liabilities increased $7.7 million or 10% from December 31, 2021 to March 31, 2022. The majority of the increase was due to deferred revenue increasing by $6.6 million reflecting a corresponding growth in revenue and a $1.0 million increase in trade payables due to increased expenses incurred to support the Company’s growth.
Quarterly Results of Operations
The following table sets forth selected unaudited quarterly statements of operations data for each of the eight quarters ended June 30, 2020 to ended March 31, 2022. The information for each of these quarters has been prepared on the same basis as the audited annual financial statements for the year ended December 31, 2021 and the unaudited condensed consolidated interim financial statements for the period ended March 31, 2022. This data should be read in conjunction with our audited annual financial statements for the year ended December 31, 2021 and the unaudited condensed consolidated interim financial statements for the period ended March 31, 2022. These quarterly operating results are not necessarily indicative of our operating results for a full year or any future period.
| Three months ended | ||||||||||||||||||||||||||
| (In thousands of US dollars, except per share data) | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | ||||||||||||||||||
| $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||
| Revenue | 32,055 | 29,801 | 27,068 | 25,631 | 21,742 | 18,756 | 16,096 | 14,535 | ||||||||||||||||||
Net (loss) income before income taxes | (6,830) | (2,887) | 1,456 | (6,397) | (5,601) | (4,521) | (713) | (3,265) | ||||||||||||||||||
Net (loss) income attributable to equity owners of the Company | (6,959) | (1,428) | 661 | (7,190) | (5,644) | (4,103) | (1,158) | (3,498) | ||||||||||||||||||
(Loss) income per share - basic | (0.21) | (0.04) | 0.02 | (0.22) | (0.17) | (0.14) | (0.04) | (0.12) | ||||||||||||||||||
(Loss) income per share - diluted | (0.21) | (0.04) | 0.02 | (0.22) | (0.17) | (0.14) | (0.04) | (0.12) | ||||||||||||||||||
14
Revenue
Our total quarterly revenue increased sequentially for all periods presented which was primarily attributable to revenue from new customers, strong revenue retention and up-selling from existing customers, and delivery of professional services to customers. We cannot provide assurance that this pattern of sequential growth in revenue will continue.
Net (Loss) Income
Net loss in the first quarter of 2022 is higher primarily due to the Company’s continued focus on growing its subscription revenue in multiple jurisdictions resulting in an increase in headcount and related employee salaries and
benefits. In addition, the Company had significant movements in unrealized foreign exchange loss as the proceeds raised from the TSX IPO, Bought Deal and Nasdaq IPO are held in US dollars.
Liquidity, Capital Resources and Financing
Overview
The general objectives of our capital management strategy are to preserve our capacity to continue operating, provide benefits to our stakeholders and provide an adequate return on investment to our shareholders by selling our platform and services at a price that is commensurate with the level of operating risk we assume. We thus determine the total amount of capital required consistent with risk levels. This capital structure is adjusted on a timely basis depending on changes in the economic environment and risks of the underlying assets. We are not subject to any externally imposed capital requirements.
Working Capital
Our primary source of cash flow is revenue from operations and equity capital raises totaling $225.4 million including net proceeds from the IPOs and the Bought Deal. Our approach to managing liquidity is to ensure, to the extent possible, that we always have sufficient liquidity to meet our liabilities as they become due. We do so by monitoring cash flow and performing budget-to-actual analysis on a regular basis.
Working capital(1) as at March 31, 2022 and 2021 was $176.4 million and $190.8 million, respectively. Working capital is defined as current assets, excluding the current portion of the net investment in finance lease and contract acquisition costs, minus current liabilities, excluding borrowings and the current portion of contingent consideration and lease obligations.
The following table represents the Company’s working capital position as at March 31, 2022 and 2021:
15
2022 | 2021 | |||||||
| $ | $ | |||||||
| Current assets | 254,624 | 240,369 | ||||||
| Deduct: | ||||||||
| Current portion of net investment in finance lease | 82 | 100 | ||||||
| Current portion of contract acquisition costs | 2,966 | 1,553 | ||||||
| Current assets, net of net investment in finance lease and contract acquisition costs | 251,576 | 238,716 | ||||||
| Current liabilities | 76,992 | 49,760 | ||||||
| Deduct: | ||||||||
| Current portion of contingent consideration | 467 | 467 | ||||||
| Current portion of lease obligations | 1,321 | 1,327 | ||||||
| Borrowings | — | 8 | ||||||
| Current liabilities, net of borrowings, contingent consideration and lease obligations | 75,204 | 47,958 | ||||||
| Working capital | 176,372 | 190,758 | ||||||
Notes:
(1)Working capital is not a recognized measure under IFRS. See “Non-IFRS Measures and Reconciliation of Non-IFRS Measures”.
Our principal cash requirements are for working capital. Given our existing cash and cash equivalents, along with net proceeds obtained from our capital raises as described above, we believe there is sufficient liquidity to meet our current and short-term growth requirements in addition to our long-term strategic objectives, and as a result we terminated the Credit Facility (as defined herein) on June 1, 2021 (see “Credit Facility” in this MD&A).
Base Shelf Prospectus
On October 22, 2020, the Company filed a short form base shelf prospectus with securities regulatory authorities in each of the provinces and territories of Canada to allow us and certain of our shareholders to qualify the distribution by way of prospectus in Canada of up to C$750 million of common shares, preferred shares, debt securities, subscription receipts, warrants, units, or any combination thereof, during the 25-month period that the base shelf prospectus is effective.
Cash Flows
The following table presents cash and cash equivalents as at March 31, 2022 and 2021, and cash flows from operating, investing, and financing activities for the three months ended March 31:
2022 | 2021 | |||||||
| $ | $ | |||||||
| Cash and cash equivalents | 211,982 | 217,384 | ||||||
| Net cash provided by (used in): | ||||||||
| Operating activities | (1,972) | (2,183) | ||||||
| Investing activities | (1,374) | (171) | ||||||
| Financing activities | 103 | (97) | ||||||
| Effect of foreign exchange on cash and cash equivalents | (98) | 177 | ||||||
| Net decrease in cash and cash equivalents | (3,341) | (2,274) | ||||||
Cash Flows Used in Operating Activities
Cash flows used in operating activities for the three months ended March 31, 2022 were $(2.0) million compared to $(2.2) million for the three months ended March 31, 2021. The decrease in cash flows used in operating activities was driven by an unfavourable change in net working capital offset by a reduction in net operating cash flow compared to the same period in the prior year. The change in net working capital of $(0.9) million was largely due to an increase in trade and other receivables, contract acquisition costs, and prepaids and deposits offset by increases
16
in trade and other payables, and deferred revenue. Trade and other receivables along with contract acquisition costs and deferred revenue movements are a result of revenue growth during the first quarter of 2022. Prepaids and deposits increased due to the prepayment of software expenditures, while trade and other payables increased as a result of higher expenses incurred to support the Company’s growth. The improvement in net operating cash flow was a result of stronger revenues while costs remained relatively consistent as a percentage of revenue compared to the same period in the year.
Cash Flows Used in Investing Activities
Cash flows used in investing activities for the three months ended March 31, 2022 were $(1.4) million compared to $(0.2) million for the three months ended March 31, 2021. Cash outflows for investing activities were higher in the due to the $1.0 million business acquisition of Skillslive.
Cash Flows from (Used in) Financing Activities
Cash flows from financing activities for the three months ended March 31, 2022 were $0.1 million compared to $(0.1) million for the three months ended March 31, 2021. The cash inflows during the first quarter of 2022 were higher as a result of the proceeds obtained from the share issuance under the ESPP.
Free Cash Flow
Free Cash Flow(1) is defined as cash used in operating activities less additions to property and equipment and intangible assets. The IFRS measure most directly comparable to Free Cash Flow presented in our financial statements is cash flow used in operating activities. The following table reconciles our cash flow used in operating activities to Free Cash Flow:
Three months ended March 31, | |||||||||||||||||
2022 | 2021 | ||||||||||||||||
| $ | $ | ||||||||||||||||
Cash flow used in operating activities | (1,972) | (2,183) | |||||||||||||||
| Additions to property and equipment | (303) | (171) | |||||||||||||||
| Free Cash Flow | (2,275) | (2,354) | |||||||||||||||
Notes:
(1)Free cash flow is not a recognized measure under IFRS. See “Non-IFRS Measures and Reconciliation of Non-IFRS Measures”.
Credit Facility
On July 25, 2019, the Company secured a credit facility from Toronto-Dominion Bank (the “Credit Facility”), which provided for the availability of up to $15 million.
On June 1, 2021, the Company terminated the Credit Facility and repaid all accrued and unpaid interest. The acceleration of unamortized costs was included in finance expense in the statement of loss. Prior to termination, the balance drawn on the facility was nil.
Use of Proceeds from the Nasdaq IPO and the Bought Deal Offering
As a result of the completed Bought Deal, the Company raised net proceeds of $18.1 million. These proceeds have been placed in cash and cash equivalents that include short-term investments in highly liquid marketable securities, having a term to maturity of three months or less. The Company’s use of proceeds from the bought deal offering has not changed from the disclosure set forth in the “Use of Proceeds” section of our short form prospectus dated August 24, 2020 to the date of this MD&A.
Additionally, as a result of the completed Nasdaq IPO, the Company raised net proceeds of $154.9 million. These proceeds have been placed in cash and cash equivalents that include short-term investments in highly liquid
17
marketable securities, having a term to maturity of three months or less. The Company’s use of proceeds from the Bought Deal has not changed from the disclosure set forth in the “Use of Proceeds” section of our prospectus supplement dated December 2, 2020 to the short form base shelf prospectus dated October 2, 2020 to the date of this MD&A.
Off-Balance Sheet Arrangements
We have not entered into off-balance sheet arrangements. Except for operating leases not recognized as ROU assets under IFRS 16, all of our liabilities and commitments are reflected as part of our statement of financial position. From time to time, we may be contingently liable with respect to litigation and claims that arise in the normal course of operations.
Related Party Transactions
In the ordinary course of business, we may provide services (including our Platform) to, and enter into contracts with, related parties on terms similar to those offered to non-related parties. We have no related party transactions, other than those noted in Note 16 in our unaudited condensed consolidated interim financial statements.
Financial Instruments and Other Instruments
Credit Risk
Generally, the carrying amount in our consolidated statement of financial position exposed to credit risk, net of any applicable provisions for losses, represents the maximum amount exposed to credit risk.
Our credit risk is primarily attributable to our cash and cash equivalents and trade and other receivables. We do not require guarantees from our customers. Credit risk with respect to cash and cash equivalents is managed by maintaining balances only with high credit quality financial institutions.
Due to our diverse customer base, there is no particular concentration of credit risk related to our trade and other receivables. Moreover, balances for trade and other receivables are managed and analyzed on an ongoing basis to ensure allowances for doubtful accounts are established and maintained at an appropriate amount.
We estimate anticipated losses from doubtful accounts based upon the expected collectability of all trade and other receivables, which estimate takes into account the number of days past due, collection history, identification of specific customer exposure and current economic trends. An impairment loss on trade and other receivables is calculated as the difference between the carrying amount and the present value of the estimated future cash flow. Impairment losses are charged to general and administrative expense in the consolidated statements of (loss) income and comprehensive loss. Receivables for which an impairment provision was recognized are written off against the corresponding provision when they are deemed uncollectible. Impairment losses for trade receivables are based on the expected credit loss model. The Company applies the simplified approach to impairment for trade and other receivables by recognizing lifetime expected losses on initial recognition through both the analysis of historical defaults and a reassessment of counterparty credit risk in revenue contracts on an annual basis. Potential effects from COVID-19 on the Company’s credit risk have been considered and have resulted in increases to its allowances for expected credit losses on customer balances. The Company continues its assessment given the fluidity of COVID-19’s global impact.
The maximum exposure to credit risk at the date hereof is the carrying value of each class of receivables mentioned above. We do not hold any collateral as security.
Foreign Currency Exchange Risk
We are exposed to currency risk due to financial instruments denominated in foreign currencies. The Company’s primary exposure with respect to foreign currencies is from U.S. dollar denominated cash and cash equivalents,
18
trade and other receivables, trade and other payables and borrowings in entities whose functional currency is other than U.S. dollars.
We have not entered into arrangements to hedge our exposure to currency risk.
Inflation Risk
We do not believe that inflation has had a material effect on our business, financial condition or results of operations. If our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, financial condition and results of operations
Critical Accounting Policies and Estimates
The preparation of our consolidated financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We review these estimates on an ongoing basis based on management’s best knowledge of current events and actions that we may undertake in the future. Actual results could differ from these estimates. Areas requiring the most significant estimates and judgments which are deemed critical are outlined below.
Revenue Recognition
Revenue recognition requires judgment and the use of estimates, especially in evaluating the various non-standard terms and conditions in our contracts with customers as to their effect on reported revenue.
The Company derives its revenues from two main sources: subscription and professional services revenue, which includes services such as initial project management and training and integration. Professional services do not include significant customization to, or development of, the software. Revenue is recognized by applying the five-step framework under IFRS 15 Revenue Recognition, as described in Note 3 of our audited annual consolidated financial statements for the year ended December 31, 2021.
The Company enters into significant revenue contracts with certain large enterprise customers that contain non-standard terms and conditions, pricing and promised services. Significant management judgement can be required to assess the impact of these items on the amount and timing of revenue recognition for these contracts including the determination of performance obligations, calculation of transaction price, allocation of transaction price across performance obligations, and timing of revenue recognition.
Outstanding Share Information
We are currently authorized to issue an unlimited number of common shares. As of the date hereof, 32,883,802 common shares, 1,272,171 stock options, 61,350 DSUs and 62,691 RSUs are issued and outstanding.
Foreign Currency Exchange (“FX”) Rates
Although our functional currency is the Canadian dollar, we have elected to report our financial results in U.S. dollars to improve the comparability of our financial results with our peers. Reporting our financial results in U.S. dollars also reduces the impact of foreign currency exchange fluctuations in the Company’s reported amounts, as our transactions denominated in U.S. dollars are significantly larger than Canadian dollars or Euros.
Our consolidated financial position and operating results have been translated to U.S. dollars applying FX rates outlined in the table below. FX rates are expressed as the amount of U.S. dollars required to purchase one Canadian dollar. FX rates represent the daily closing rate published by Thomson Reuters.
19
Period | Consolidated Statement of Financial Position | Consolidated Statement of (Loss) Income and Comprehensive Loss | |||||||||
Current Rate | Average Rate | ||||||||||
Three months ended March 31, 2021 | $0.7935 | $0.7874 | |||||||||
Three months ended March 31, 2022 | $0.7981 | $0.7890 | |||||||||
Disclosure Controls and Procedures and Internal Controls over Financial Reporting
Management of the Company, under the supervision of the Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining disclosure controls and procedures (as defined under applicable Canadian securities laws and by the United States Securities and Exchange Commission (“SEC”) in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (“the Exchange Act”) for the Company to ensure that material information relating to the Company, including its consolidated subsidiaries, that is required to be made known to the Chief Executive Officer and Chief Financial Officer by others within the Company and disclosed by the Company in reports filed or submitted by it under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms; and (ii) accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.
The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed by, or under the supervision of, the Chief Executive Officer and the Chief Financial Officer and effected by the Company’s board of directors, management and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board.
Management determined that there were no material weaknesses in the Registrant’s internal control over financial reporting as of March 31, 2022.
There have been no changes to the Company’s internal controls over financial reporting during the quarter ended March 31, 2022 that have materially affected, or are reasonably likely to materially affect, its internal controls over financial reporting.
20
Exhibit 99.3
Docebo Reports First Quarter 2022 Results
Revenue growth of 47% and ARR growth of 55% on continued new customer and ACV growth
TORONTO, ONTARIO - May 12, 2022 - Docebo Inc. (NASDAQ: DCBO; TSX:DCBO) (“Docebo” or the “Company”), a leading artificial intelligence (AI)-powered learning suite, today announced financial results for the three months ended March 31, 2022. All amounts are expressed in US dollars unless otherwise stated.
“Strong execution enabled our Company to deliver another quarter of excellent results across the board,” said Claudio Erba, CEO and Founder of Docebo. “Docebo is at the forefront of a long secular growth trend driven by companies using learning technologies to solve mission critical challenges. We see this macro trend creating a prolonged demand opportunity that is enabling employees, customers and other stakeholders to drive favourable business outcomes.”
First Quarter 2022 Financial Highlights
•Revenue of $32.1 million, an increase of 47% from the comparative period in the prior year
•Subscription revenue of $29.1 million, representing 91% of total revenue, and an increase of 47% from the comparative period in the prior year
•Gross profit of $25.5 million, an increase of 43% from the comparative period in the prior year, or 80% of revenue compared to 82% of revenue for the comparative period in the prior year
•Net loss of $7.0 million, or $0.21 per share, compared to net loss of $5.6 million, or $0.17 per share for the comparative period in the prior year
•Annual Recurring Revenue1, 2 as at March 31, 2022 of $129.3 million, an increase of $45.9 million from $83.4 million at the end of the first quarter of 2021, or an increase of 55%
•Adjusted EBITDA2 loss of $1.3 million compared to adjusted EBITDA loss of $2.5 million for the comparative period in the prior year
•Negative cash flow generated from operating activities of $2.0 million, compared to negative $2.2 million for the comparative period in the prior year
•Free cash flow2 of negative $2.3 million compared to negative $2.4 million for the comparative period in the prior year
1 Please refer to “Key Performance Indicators” section of this press release.
2 Please refer to “Non-IFRS Measures and Reconciliation of Non-IFRS Measures” section of this press release.
First Quarter 2022 Business Highlights
•Docebo is now used by 2,947 customers, an increase from 2,333 customers at the end of March 31, 2021.
•Strong growth in average contract value (“ACV”), calculated as total Annual Recurring Revenue divided by the number of active customers, increasing from $35,739 as at March 31, 2021 to $43,875 as at March 31, 2022.
•Strong new logo wins including a new customer agreement with Bridgestone Americas, a leader in tires and sustainable mobility solutions, to deliver intuitive and personalized learning experience to more than 20,000 Bridgestone retail employees in the United States.
•Affirm, a leading Silicon Valley fintech company, selected Docebo to provide a more streamlined approach to compliance training and onboarding with a more modern learning experience.
•The largest cryptocurrency exchange in the United States chose Docebo to be their long-term Learning Suite provider. Docebo will support their Customer Experience team as they prepare to launch an internal employee and external customer & partner training platform for their 185,000 ecosystem partners and 3,700 employees with future plans to launch a public corporate university demonstrating the scalability of the Docebo Learning Suite.
•A global leader in workflow automation software was searching for a learning solutions partner capable of delivering an innovative, personalized learning experience for their employees. They chose the Docebo LMS and the Docebo Learning Suite to address their internal learning requirements because of Docebo's ability to integrate with other business tools they're using and its robust performance.
1
•Smoothie King selected Docebo as their learning management system to create personalized learning experiences to train all their global franchise employees across their more than 1300 locations in the United States and internationally as well as their corporate HQ teams within a single learning environment. The increased investment in learning and development is focused on helping Smoothie King open more than 100 stores every year.
•Fortune 500 telecommunications and real estate investment trust American Tower selected Docebo to satisfy their needs and have all the functionality of a Learning Management System (“LMS”), Learning Experience Platform (“LXP”) and Learning Record Store (“LRS”) in one easy to use platform. They have invested in their future with Docebo's learning suite including Learning Analytics, Shape and Connect and will utilize the suite to train more than 5,000 employees.
•A North American chain of luxury department stores expanded its agreement with Docebo following a successful deployment to their corporate team that started in the third quarter of 2021. The expansion will see Docebo used within their full retail group for the onboarding and upskilling of associates via a custom mobile-first solution.
•Stambaugh Ness, a multi-discipline, professional services firm with a strategic focus on the architecture and engineering, professional services, construction, real estate, and manufacturing industries, has chosen Docebo Learn LMS for the training and education of their clients. An integral part of their LMS deployment will include Docebo Shape as they seek to increase learner engagement and maximize critical knowledge sharing across their organization.
First Quarter 2022 Results
Selected Financial Measures
Three months ended March 31, | |||||||||||||||||||||||||||||
2022 | 2021 | Change | Change | ||||||||||||||||||||||||||
| $ | $ | $ | % | ||||||||||||||||||||||||||
| Subscription Revenue | 29,128 | 19,775 | 9,353 | 47.3 | % | ||||||||||||||||||||||||
| Professional Services | 2,927 | 1,967 | 960 | 48.8 | % | ||||||||||||||||||||||||
| Total Revenue | 32,055 | 21,742 | 10,313 | 47.4 | % | ||||||||||||||||||||||||
| Gross Profit Margin | 25,503 | 17,878 | 7,625 | 42.7 | % | ||||||||||||||||||||||||
| Percentage of Total Revenue | 79.6 | % | 82.2 | % | |||||||||||||||||||||||||
| Net Loss | (6,959) | (5,644) | (1,315) | (23.3) | % | ||||||||||||||||||||||||
| Cash Used in Operating Activities | (1,972) | (2,183) | 211 | 9.7 | % | ||||||||||||||||||||||||
Key Performance Indicators
As at March 31, | ||||||||||||||
2022 | 2021 | Change | Change % | |||||||||||
| Annual Recurring Revenue (in millions of US dollars) | 129.3 | 83.4 | 45.9 | 55.0 | % | |||||||||
| Average Contract Value (in thousands of US dollars) | 43.9 | 35.7 | 8.2 | 23.0 | % | |||||||||
| Customers | 2,947 | 2,333 | 614 | 26.3 | % | |||||||||
Non-IFRS Metrics
Three months ended March 31, | |||||||||||||||||||||||||||||
2022 | 2021 | Change | Change | ||||||||||||||||||||||||||
| $ | $ | $ | % | ||||||||||||||||||||||||||
| Adjusted EBITDA | (1,288) | (2,473) | 1,185 | 47.9 | % | ||||||||||||||||||||||||
| Working Capital | 176,372 | 190,758 | (14,386) | (7.5) | % | ||||||||||||||||||||||||
| Free Cash Flow | (2,275) | (2,354) | 79 | 3.4 | % | ||||||||||||||||||||||||
Conference Call
Management will host a conference call on Thursday, May 12, 2022 at 8:00 am ET to discuss these first quarter results. To access the conference call, please dial 416-764-8688 or 1-888-390-0546 or access the webcast at https://bit.ly/3uPlZzq. The unaudited condensed consolidated interim financial statements for the three months ended March 31, 2022 and Management’s Discussion & Analysis for the same period have been filed on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
2
Alternatively, these documents along with a presentation in connection with the conference call can be accessed online at https://investors.docebo.com.
An archived recording of the conference call will be available until May 19, 2022 and for 90 days on our website. To listen to the recording, please visit the webcast link or call 416-764-8677 or 1-888-390-0541 and enter passcode 510496.
Forward-looking Information
This press release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking information”) within the meaning of applicable securities laws. Forward-looking information may relate to our future financial outlook and anticipated events or results and may include information regarding our financial position, business strategy, the ongoing impact of COVID-19 on our business, growth strategies, addressable markets, budgets, operations, financial results, taxes, dividend policy, plans and objectives. Particularly, information regarding our expectations of future results, performance, achievements, prospects or opportunities or the markets in which we operate is forward-looking information.
In some cases, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects”, “is expected”, “an opportunity exists”, “budget”, “scheduled”, “estimates”, “outlook”, “forecasts”, “projection”, “prospects”, “strategy”, “intends”, “anticipates”, “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or, “will”, “occur” or “be achieved”, and similar words or the negative of these terms and similar terminology. In addition, any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates and projections regarding future events or circumstances.
This forward-looking information includes, but is not limited to, statements regarding the Company’s business; future financial position and business strategy; the learning management industry; our growth rates and growth strategies; addressable markets for our solutions; the achievement of advances in and expansion of our platform; expectations regarding our revenue and the revenue generation potential of our platform and other products; our business plans and strategies; and our competitive position in our industry. This forward-looking information is based on our opinions, estimates and assumptions in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we currently believe are appropriate and reasonable in the circumstances. Despite a careful process to prepare and review the forward-looking information, there can be no assurance that the underlying opinions, estimates and assumptions will prove to be correct. Certain assumptions include: our ability to build our market share and enter new markets and industry verticals; our ability to attract and retain key personnel; our ability to maintain and expand geographic scope; our ability to execute on our expansion plans; our ability to continue investing in infrastructure to support our growth; our ability to obtain and maintain existing financing on acceptable terms; our ability to execute on profitability initiatives; currency exchange and interest rates; the impact of inflation; the impact of competition; the effectiveness of mitigation strategies undertaken with respect to COVID-19, and the severity, duration and impacts of COVID-19 on the economy and our business, which is highly uncertain and cannot reasonably be predicted; our ability to respond to the changes and trends in our industry or the global economy; and the changes in laws, rules, regulations, and global standards are material factors made in preparing forward-looking information and management’s expectations.
Forward-looking information is necessarily based on a number of opinions, estimates and assumptions that, while considered by the Company to be appropriate and reasonable as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to:
•the Company’s ability to execute its growth strategies;
•the impact of changing conditions in the global corporate e-learning market;
•increasing competition in the global corporate e-learning market in which the Company operates;
•fluctuations in currency exchange rates and volatility in financial markets;
•the extent of the impact of COVID-19 on our results of operations and overall financial performance;
•changes in the attitudes, financial condition and demand of our target market;
•developments and changes in applicable laws and regulations; and
•such other factors discussed in greater detail under the “Risk Factors” section of our Annual Information Form dated March 9, 2022 (“AIF”), which is available under our profile on SEDAR at www.sedar.com.
If any of these risks or uncertainties materialize, or if the opinions, estimates or assumptions underlying the forward-looking information prove incorrect, actual results or future events might vary materially from those anticipated in the forward-looking
3
information. The opinions, estimates or assumptions referred to above and described in greater detail in the “Summary of Factors Affecting our Performance” section of our MD&A for the three months ended March 31, 2022 and in the “Risk Factors” section of our AIF, should be considered carefully by prospective investors.
Although we have attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other risk factors not presently known to us or that we presently believe are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. No forward-looking statement is a guarantee of future results. Accordingly, you should not place undue reliance on forward-looking information, which speaks only as of the date made. The forward-looking information contained in this press release represents our expectations as of the date specified herein, and are subject to change after such date. However, we disclaim any intention or obligation or undertaking to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable securities laws.
All of the forward-looking information contained in this press release is expressly qualified by the foregoing cautionary statements.
Additional information relating to Docebo, including our AIF, can be found on SEDAR at www.sedar.com.
About Docebo
Docebo is redefining the way enterprises leverage technology to create and manage content, deliver training, and understand the business impact of their learning experiences. With Docebo’s multi-product learning suite, enterprises around the world are equipped to tackle any learning challenge and create a true learning culture within their organization.
For further information, please contact:
Mike McCarthy
Vice President - Investor Relations
(214) 830-0641
mike.mccarthy@docebo.com
Results of Operations
The following table outlines our unaudited condensed consolidated interim statements of loss and comprehensive loss for the following periods:
Three months ended March 31, | ||||||||||||||||||||
| (In thousands of US dollars, except per share data) | 2022 | 2021 | ||||||||||||||||||
| $ | $ | |||||||||||||||||||
| Revenue | 32,055 | 21,742 | ||||||||||||||||||
| Cost of revenue | 6,552 | 3,864 | ||||||||||||||||||
| Gross profit | 25,503 | 17,878 | ||||||||||||||||||
| Operating expenses | ||||||||||||||||||||
| General and administrative | 7,375 | 7,437 | ||||||||||||||||||
| Sales and marketing | 13,747 | 9,119 | ||||||||||||||||||
| Research and development | 6,186 | 4,143 | ||||||||||||||||||
| Share-based compensation | 1,094 | 378 | ||||||||||||||||||
Foreign exchange loss | 3,391 | 1,951 | ||||||||||||||||||
| Depreciation and amortization | 580 | 474 | ||||||||||||||||||
| 32,373 | 23,502 | |||||||||||||||||||
Operating loss | (6,870) | (5,624) | ||||||||||||||||||
| Finance income, net | (19) | (2) | ||||||||||||||||||
| Other income | (21) | (21) | ||||||||||||||||||
4
Loss before income taxes | (6,830) | (5,601) | ||||||||||||||||||
Income tax expense | 129 | 43 | ||||||||||||||||||
Net loss for the period | (6,959) | (5,644) | ||||||||||||||||||
Other comprehensive income | ||||||||||||||||||||
| Item that may be reclassified subsequently to income: | ||||||||||||||||||||
Exchange gain on translation of foreign operations | (3,212) | (2,114) | ||||||||||||||||||
Comprehensive loss | (3,747) | (3,530) | ||||||||||||||||||
Loss per share - basic and diluted | (0.21) | (0.17) | ||||||||||||||||||
| Weighted average number of common shares outstanding - basic and diluted | 33,017,421 | 32,781,080 | ||||||||||||||||||
Key Statement of Financial Position Information
(In thousands of US dollars, except percentages) | March 31, 2022 | December 31, 2021 | Change | Change | |||||||||||||
| $ | $ | $ | % | ||||||||||||||
Cash and cash equivalents | 211,982 | 215,323 | (3,341) | (1.6) | % | ||||||||||||
Total assets | 273,519 | 268,123 | 5,396 | 2.0 | % | ||||||||||||
Total liabilities | 85,192 | 77,467 | 7,725 | 10.0 | % | ||||||||||||
Total long-term liabilities | 8,200 | 8,294 | (94) | (1.1) | % | ||||||||||||
Non-IFRS Measures and Reconciliation of Non-IFRS Measures
This press release makes reference to certain non-IFRS measures including key performance indicators used by management and typically used by our competitors in the software-as-a-service (“SaaS”) industry. These measures are not recognized measures under IFRS and do not have a standardized meaning prescribed by IFRS and are therefore not necessarily comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of our results of operations from management’s perspective. Accordingly, these measures should not be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS. These non-IFRS measures are used to provide investors with alternative measures of our operating performance and liquidity and thus highlight trends in our business that may not otherwise be apparent when relying solely on IFRS measures. We also believe that securities analysts, investors and other interested parties frequently use non-IFRS measures, including SaaS industry metrics, in the evaluation of companies in the SaaS industry. Management also uses non-IFRS measures to facilitate operating performance comparisons from period to period, the preparation of annual operating budgets and forecasts and to determine components of executive compensation. The non-IFRS measures referred to in this press release include “Annual Recurring Revenue”, “Adjusted EBITDA”, “Working Capital” and “Free Cash Flow”.
Key Performance Indicators
We recognize subscription revenues ratably over the term of the subscription period under the provisions of our agreements with customers. The terms of our agreements, combined with high customer retention rates, provides us with a significant degree of visibility into our near-term revenues. Management uses a number of metrics, including the ones identified below, to measure the Company’s performance and customer trends, which are used to prepare financial plans and shape future strategy. Our key performance indicators may be calculated in a manner different than similar key performance indicators used by other companies.
•Annual Recurring Revenue: We define Annual Recurring Revenue as the annualized equivalent value of the subscription revenue of all existing contracts (including Original Equipment Manufacturer (“OEM”) contracts) as at the date being measured, excluding non-recurring revenues from implementation, support and maintenance fees. Our customers generally enter into one to three year contracts which are non-cancellable or cancellable with penalty. Accordingly, our calculation of Annual Recurring Revenue assumes that customers will renew the contractual commitments on a periodic basis as those commitments come up for renewal. Subscription agreements may be subject to price increases upon renewal reflecting both inflationary increases and the additional value provided by our
5
solutions. In addition to the expected increase in subscription revenue from price increases over time, existing customers may subscribe for additional features, learners or services during the term. We believe that this measure provides a fair real-time measure of performance in a subscription-based environment. Annual Recurring Revenue provides us with visibility for consistent and predictable growth to our cash flows. Our strong total revenue growth coupled with increasing Annual Recurring Revenue indicates the continued strength in the expansion of our business and will continue to be our focus on a go-forward basis.
Annual Recurring Revenue was as follows as at March 31:
2022 | 2021 | Change | Change % | ||||||||||||||
| Annual Recurring Revenue (in millions of US dollars) | 129.3 | 83.4 | 45.9 | 55.0% | |||||||||||||
Adjusted EBITDA
EBITDA is defined as net loss before amortization and depreciation expenses, net finance (income) expense, and income taxes.
Adjusted EBITDA is defined as net loss excluding taxes (if applicable), net finance (income) expense, depreciation and amortization, loss on disposal of assets (if applicable), share-based compensation, foreign exchange gains and losses, acquisition related compensation and transaction related expenses.
The IFRS measure most directly comparable to Adjusted EBITDA presented in our financial statements is net loss.
The following table reconciles Adjusted EBITDA to net loss for the periods indicated:
Three months ended March 31, | |||||||||||||||||
(In thousands of US dollars) | 2022 | 2021 | |||||||||||||||
| $ | $ | ||||||||||||||||
Net loss | (6,959) | (5,644) | |||||||||||||||
Finance income, net(1) | (19) | (2) | |||||||||||||||
Depreciation and amortization(2) | 580 | 474 | |||||||||||||||
Income tax expense | 129 | 43 | |||||||||||||||
| EBITDA | (6,269) | (5,129) | |||||||||||||||
Share-based compensation(3) | 1,215 | 378 | |||||||||||||||
Other income(4) | (21) | (21) | |||||||||||||||
Foreign exchange loss(5) | 3,391 | 1,951 | |||||||||||||||
Acquisition related compensation(6) | 295 | 102 | |||||||||||||||
Transaction related expenses(7) | 101 | 246 | |||||||||||||||
| Adjusted EBITDA | (1,288) | (2,473) | |||||||||||||||
Notes:
(1)Finance income, net, for the three months ended March 31, 2022 is primarily related to interest income earned on the net proceeds from the IPOs as the funds are held within short-term investments in highly liquid marketable securities which is offset by interest expenses incurred on the credit facility, lease obligations and contingent consideration.
(2)Depreciation and amortization expense is primarily related to depreciation expense on right-of-use assets (“ROU assets”), property and equipment and acquired intangible assets.
(3)These expenses represent non-cash expenditures recognized in connection with the issuance of share-based compensation to our employees and directors and cash payroll taxes paid on gains earned by option holders when stock options are exercised.
(4)Other income is primarily comprised of rental income from subleasing office space.
(5)These non-cash gains and losses relate to foreign exchange loss.
6
(6)These costs represent acquisition related retention incentives associated with the achievement of both yearly performance milestones and continued employment for employees of the acquiree.
(7)These expenses relate to professional, legal, consulting, accounting and other fees related to acquisition activities and the Nasdaq IPO in December 2020 that would otherwise have not been incurred and are not considered an expense indicative of continuing operations.
Working Capital
Working Capital as at March 31, 2022 and 2021 was $176.4 million and $190.8 million, respectively. Working capital is defined as current assets, excluding the current portion of the net investment in finance lease and contract acquisition costs, minus current liabilities, excluding borrowings and the current portion of contingent consideration and lease obligations.
The following table represents the Company’s working capital position as at March 31, 2022 and 2021:
2022 | 2021 | |||||||
| $ | $ | |||||||
| Current assets | 254,624 | 240,369 | ||||||
| Deduct: | ||||||||
| Current portion of net investment in finance lease | 82 | 100 | ||||||
| Current portion of contract acquisition costs | 2,966 | 1,553 | ||||||
| Current assets, net of net investment in finance lease and contract acquisition costs | 251,576 | 238,716 | ||||||
| Current liabilities | 76,992 | 49,760 | ||||||
| Deduct: | ||||||||
| Current portion of contingent consideration | 467 | 467 | ||||||
| Current portion of lease obligations | 1,321 | 1,327 | ||||||
| Borrowings | — | 8 | ||||||
| Current liabilities, net of borrowings, contingent consideration and lease obligations | 75,204 | 47,958 | ||||||
| Working capital | 176,372 | 190,758 | ||||||
Free Cash Flow
Free Cash Flow is defined as cash used in operating activities less additions to property and equipment and intangible assets. The IFRS measure most directly comparable to Free Cash Flow presented in our financial statements is cash flow used in operating activities. The following table reconciles our cash flow used in operating activities to Free Cash Flow:
Three months ended March 31, | |||||||||||||||||
(In thousands of US dollars) | 2022 | 2021 | |||||||||||||||
| $ | $ | ||||||||||||||||
Cash flow used in operating activities | (1,972) | (2,183) | |||||||||||||||
Additions to property and equipment | (303) | (171) | |||||||||||||||
Free Cash Flow | (2,275) | (2,354) | |||||||||||||||
FORM 52-109F2
CERTIFICATION OF INTERIM FILINGS
FULL CERTIFICATE
CERTIFICATION OF INTERIM FILINGS
FULL CERTIFICATE
I, Claudio Erba, Chief Executive Officer of Docebo Inc., certify the following:
1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Docebo Inc. (the “issuer”) for the interim period ended March 31, 2022.
2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.
3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.
4. Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings, for the issuer.
5. Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings
A.designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that
I.material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and
II.information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and
B.designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.
5.1 Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the issuer’s ICFR is Internal Control – Integrated Framework (COSO 2013 Framework) published by The Committee of Sponsoring Organizations of the Treadway Commission.
5.2 N/A
5.3 N/A
6. Reporting changes in ICFR: The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on January 1, 2022 and ended on March 31, 2022 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.
Date: May 12, 2022
/s/ Claudio Erba
_______________________
Claudio Erba
Chief Executive Officer
FORM 52-109F2
CERTIFICATION OF INTERIM FILINGS
FULL CERTIFICATE
CERTIFICATION OF INTERIM FILINGS
FULL CERTIFICATE
I, Sukaran Mehta, Chief Financial Officer of Docebo Inc., certify the following:
1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Docebo Inc. (the “issuer”) for the interim period ended March 31, 2022.
2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.
3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.
4. Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings, for the issuer.
5. Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings
A.designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that
I.material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and
II.information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and
B.designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.
5.1 Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the issuer’s ICFR is Internal Control – Integrated Framework (COSO 2013 Framework) published by The Committee of Sponsoring Organizations of the Treadway Commission.
5.2 N/A
5.3 N/A
6. Reporting changes in ICFR: The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on January 1, 2022 and ended on March 31, 2022 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.
Date: May 12, 2022
/s/ Sukaran Mehta
_______________________
Sukaran Mehta
Chief Financial Officer